Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in 46 countries and approximately 48,000 employees globally, Cardinal Health is essential to care.

Company profile
Ticker
CAH
Exchange
Website
CEO
Michael Kaufmann
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CARDINAL DISTRIBUTION INC
SEC CIK
Corporate docs
Subsidiaries
A+ Secure Packaging, LLC • Aero-Med, LLC • Allegiance Corporation • Blue Robin, LLC • Cardinal Health 2, LLC • Cardinal Health 3, LLC • Cardinal Health 5, LLC • Cardinal Health 6, Inc. • Cardinal Health 7, LLC • Cardinal Health 100, LLC ...
IRS number
310958666
CAH stock data
Analyst ratings and price targets
Latest filings (excl ownership)
SD
Conflict minerals disclosure
31 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
11 May 23
10-Q
2023 Q3
Quarterly report
4 May 23
8-K
Cardinal Health Reports Third Quarter Fiscal Year 2023 Results
4 May 23
8-K
Entry into a Material Definitive Agreement
2 Mar 23
10-Q
2023 Q2
Quarterly report
2 Feb 23
8-K
Cardinal Health Reports Second Quarter Fiscal Year 2023 Results
2 Feb 23
8-K
Cardinal Health Names Aaron Alt Chief Financial Officer
19 Dec 22
8-K
Submission of Matters to a Vote of Security Holders
10 Nov 22
S-3ASR
Automatic shelf registration
8 Nov 22
Transcripts
CAH
Earnings call transcript
2023 Q3
4 May 23
CAH
Earnings call transcript
2023 Q2
2 Feb 23
CAH
Earnings call transcript
2023 Q1
4 Nov 22
CAH
Earnings call transcript
2022 Q4
11 Aug 22
CAH
Earnings call transcript
2022 Q3
5 May 22
CAH
Earnings call transcript
2022 Q2
3 Feb 22
CAH
Earnings call transcript
2022 Q1
9 Nov 21
CAH
Earnings call transcript
2021 Q4
5 Aug 21
CAH
Earnings call transcript
2021 Q3
6 May 21
CAH
Earnings call transcript
2021 Q2
5 Feb 21
Latest ownership filings
4
Jason M. Hollar
17 May 23
4
Jessica L Mayer
16 Mar 23
4
Michelle D. Greene
16 Mar 23
4
Aaron E Alt
16 Feb 23
3
Aaron E Alt
16 Feb 23
SC 13G/A
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 23
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
SC 13G/A
STATE STREET CORP
6 Feb 23
SC 13G/A
BlackRock Inc.
26 Jan 23
SC 13G/A
BlackRock Inc.
20 Jan 23
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 22 | Jun 21 | Jun 20 | Jun 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q1 2023
85.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 865 |
Opened positions | 77 |
Closed positions | 117 |
Increased positions | 295 |
Reduced positions | 340 |
13F shares | Current |
---|---|
Total value | 16.26 tn |
Total shares | 216.92 mm |
Total puts | 1.31 mm |
Total calls | 3.21 mm |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 32.74 mm | $2.47 tn |
BLK Blackrock | 29.37 mm | $2.22 tn |
STT State Street | 15.59 mm | $1.18 tn |
FMR | 6.20 mm | $468.24 bn |
MS Morgan Stanley | 5.44 mm | $410.58 bn |
Geode Capital Management | 5.40 mm | $406.56 bn |
T. Rowe Price | 4.64 mm | $349.64 bn |
IVZ Invesco | 4.34 mm | $327.70 bn |
Arrowstreet Capital, Limited Partnership | 3.75 mm | $282.55 bn |
NTRS Northern Trust | 3.29 mm | $248.65 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 May 23 | Jason M. Hollar | Common Shares | Payment of exercise | Dispose F | No | No | 84.77 | 3,037 | 257.45 k | 144,203 |
15 Mar 23 | Michelle D. Greene | Common Shares | Payment of exercise | Dispose F | No | No | 70.72 | 669 | 47.31 k | 13,655 |
15 Mar 23 | Mayer Jessica L | Common Shares | Payment of exercise | Dispose F | No | No | 70.72 | 1,336 | 94.48 k | 101,775 |
15 Feb 23 | Alt Aaron E | Common Shares | Grant | Acquire A | No | No | 0 | 12,726 | 0.00 | 12,726 |
News
Cardinal Health Board Of Directors Approve Increase To Quarterly Dividend To $0.5006 Per Share
11 May 23
Citigroup Maintains Neutral on Cardinal Health, Raises Price Target to $88
8 May 23
Deutsche Bank Maintains Hold on Cardinal Health, Raises Price Target to $90
8 May 23
Barclays Maintains Equal-Weight on Cardinal Health, Raises Price Target to $88
5 May 23
Cardinal Health Q3 Earnings Beats Estimates On Pharmaceutical Segment Strength, Raises Annual Profit Forecast
4 May 23
Press releases
Politan Calls on Shareholders to Elect Independent Oversight to Masimo's Board
23 May 23
Cardinal Health Board of Directors Approves Increase to Quarterly Dividend
11 May 23
Cardinal Health Canada to open new distribution center in Ontario
10 May 23
Cardinal Health Reports Third Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance
4 May 23
Politan Nominates Two Candidates for Masimo Board
2 May 23